Palliative Medicine
Share

Palliative Medicine

The Research Journal of the EAPC - A Multiprofessional Journal

2014 Impact Factor: 2.855
2014 Ranking: 34/162 in Public, Environmental & Occupational Health (SCI) | 27/153 in Medicine, General & Internal | 18/89 in Health Care Sciences & Services
Source: 2014 Journal Citation Reports ® (Thomson Reuters, 2015)

Editor-in-Chief
Catherine Walshe Lancaster University, UK
Editorial Manager
Debbie Ashby University of Bristol, UK
Editors
Nathan Cherny Shaare Zedek Medical Center, Israel
Jim Cleary University of Wisconsin, Madison, USA
Marie Fallon University of Edinburgh, UK
Karen Forbes University of Bristol, UK
Jane Gibbins University of Bristol, UK
Stein Kaasa Norwegian University of Science & Technology, Norway
Colette Reid University Hospitals Bristol NHS Foundation Trust, UK
Jane Seymour School of Sciences, University of Nottingham, UK
Jenny van der Steen VU University Medical Center, The Netherlands
Sarah Yardley Central & North West London NHS Foundation Trust, UK
Statistical Editor
Henrik Støvring Aarhus University, Denmark

eISSN: 1477030X| ISSN: 02692163|Current volume: 29|Current issue: 7 Frequency: 10 Times/Year

Editor's Palliative Medicine Facebook page - Click here to visit. Remember to “like” the page to receive updates and commentary on featured articles.

Palliative Medicine is a highly ranked, peer reviewed scholarly journal dedicated to improving knowledge and clinical practice in the palliative care of patients with far advanced disease. It reflects the multidisciplinary approach that is the hallmark of effective palliative care.

Essential reading for all members of the palliative care team:

  • Doctors
  • Nurses
  • Physiotherapists
  • Psychologists
  • Social workers
  • The clergy
  • Occupational therapists

A practical journal to assist you with the palliative care of patients.

This journal is a member of the Committee on Publication Ethics (COPE).

Palliative Medicine is a highly ranked, peer-reviewed scholarly journal dedicated to improving knowledge and clinical practice in the palliative care of patients with far advanced disease. It reflects the multidisciplinary approach that is the hallmark of effective palliative care.

This outstanding journal features:

  • Editorials
  • Original papers
  • Review articles
  • Case reports
  • Correspondence
  • Journal abstracts
  • Book reviews
  • Teaching package reviews

Essential reading for all members of the palliative care team:

  • Doctors
  • Nurses
  • Physiotherapists
  • Psychologists
  • Social workers
  • The clergy
  • Occupational therapists

A practical journal to assist you with the palliative care of patients.

Editorial Advisory Board
Zipporah Ali Kenya Hospices and Palliative Care Association (KEHPCA), Kenya
Samar Aoun Perth, Australia
Jason Boland University of Hull, UK
Eduardo Bruera The University of Texas, USA
Augusto Caraceni Fondazione IRCCS Istituto Nazionale dei Tumori, Italy
Carlos Centeno Universidad de Navarra, Spain
David Clark University of Glasgow, UK
Jessica Corner University of Southampton, UK
Franco De Conno Istituto Nazionale Dei Tumori, Italy
Luc Deliens Vrije University Medical Center, the Netherlands
Derek Doyle Edinburgh, UK
Jorge Eisenchlas Asociación Latinoamericana de Cuidados Paliativos, Argentina
Gail Eva UCL, UK
Robin Fainsinger Grey Nuns Community Hospital, Canada
Kathleen Foley Memorial Sloan-Kettering Cancer Center, New York, USA
Clare Gardiner Auckland, New Zealand
Cynthia Goh Assisi Home and Hospice, Singapore
Gunn Grande University of Manchester, UK
Irene J Higginson King's College London, UK
Jo Hockley St Christopher's Hospice, UK
Peter Hudson The University of Melbourne, Australia
Stephen Kirkham Poole General Hospital, UK
Caprice A. Knapp Pennsylvania State University
Sean Morrison Mt Sinai School of Medicine, USA
Simon Noble Cardiff University, UK
Sheila Payne Lancaster University, UK
Jose Pereira L'Hôpital d'Ottawa, Canada
Josep Porta I Sales Barcelona, Spain
Lukas Radbruch Universitätsklinikum Bonn, Germany
M. R. Rajagopal Trivandrum Institute of Palliative Sciences, Inda
Judith Rietjens Erasmus MC, The Netherlands
Per Sjøgren University of Copenhagen, Denmark
Franco Toscani Lino Maestroni Foundation, Italy
Satoru Tsuneto Kyoto University, Japan
James A Tulsky Duke University, USA
Mary Vachon University of Toronto, Canada
  • Academic Search Premier
  • Applied Social Sciences Index & Abstracts (ASSIA)
  • BIOSIS database
  • Biological Abstracts Family of Products
  • British Nursing Index
  • Brs
  • Cumulative Index to Nursing and Allied Health Literature CINAHL
  • Current Clinical Cancer
  • Current Contents / Clinical Medicine
  • EMBASE/Excerpta Medica
  • Etsi
  • Health Care Database
  • Heath Care Database
  • ISI Discovery Agent
  • Index Medicus
  • Index Medicus (Ceased 2004)
  • Inventory of Marriage and Family Literature
  • MEDLINE
  • Mental Health Abstracts (online through DIALOG)
  • Physiotherapy Evidence Database (PEDRO)
  • Progress in Palliative Care
  • PsycINFO
  • PsycLIT
  • Psychology & Behavioral Sciences Collection
  • Science Citation Index
  • Science Citation Index Expanded
  • Scopus
  • Siic
  • Sociedad Iberoamericana de Informacisn Cientmfica (SIIC)
  • Thomson Reuters: BIOSIS Previews
  • Thomson Reuters: Biological Abstracts
    1. General instructions to authors
          1.1) Article types
          1.2) Titles and abstracts
          Structured abstracts
          1.3) Key statements
          1.4) Study discussion
          1.5) Case report instructions for Palliative Medicine
          1.6) Case report format
    2. Editorial policies
          2.1) Peer review policy
          2.2) Authorship
          2.3) Multiple publications
          2.4) Acknowledgements
          2.5) Writing assistance
          2.6) Funding
          2.7) Declaration of conflict of interest
          2.8) Research ethics and patient consent
          2.9) Clinical trials
          2.10) Reporting guidelines
          2.11) Data
    3. Publishing Policies
          3.1) Publication ethics
          3.2) Plagiarism
          3.3) Contributor’s publishing agreement
          3.4) Open access and author archiving
          3.5) Permissions
    4. Preparing your manuscript
          4.1) Word processing formats
          4.2) Artwork, figures and other graphics
          4.3) Supplementary material
          4.4) Journal layout
          4.5) Reference style
          4.6) English language editing services
    5. Submitting your manuscript
          5.1) How to submit your manuscript
          5.2) Title, keywords and abstracts
          5.3) Corresponding author contact details
    6. On acceptance and publication
          6.1) SAGE Production
          6.2) Access to your published article
          6.3) Online First publication
    7. Further Information

    Palliative Medicine is a highly ranked, peer reviewed scholarly journal dedicated to improving knowledge and clinical practice in the palliative care of patients with far advanced disease. It reflects the multi-disciplinary and multi-professional approach that is the hallmark of effective palliative care. Papers are selected for publication based on their scientific excellence, contribution to knowledge, and their importance to contemporary palliative care. We welcome papers relating to palliative care clinical practice, policy, theory and methodological knowledge.

    Palliative Medicine is an international journal, and is the official research journal of the European Association for Palliative Care and a journal of the Association of Palliative Medicine.  This Journal is a member of the Committee on Publication Ethics. This Journal recommends that authors follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    There are no fees payable to submit or publish in this journal.

    Please read the guidelines below then visit the Journal’s submission site https://mc.manuscriptcentral.com/palliative-medicine to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Palliative Medicine will be reviewed.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    1. General instructions to authors

    We wish papers published by Palliative Medicine to adhere to the highest publishing standards possible, and be clearly written so that the key messages for our readers are explicitly articulated. Please remember that Palliative Medicine is an international journal with authors, reviewers and readers from around the world. You must make sure that your work is contextualised for such a readership.

    Back to top

     

    1.1 Article types

    Palliative Medicine publishes original research and review articles on all aspects of palliative care. The Journal considers the following kinds of article for publication:

    Palliative Medicine publishes original research and review articles on all aspects of palliative care. The Journal considers the following kinds of article for publication:

    1. Review Articles - 5,000 words. The reviews we publish are usually systematically constructed reviews, clearly following the relevant publication guidelines (such as PRISMA) for the particular review style chosen. We are happy to consider a range of review types (systematic reviews, meta- analysis, meta-ethnography, realist review for example) for publication, but they must be methodologically clear and rigorously conducted.
    2. Original Articles - 3,000 words with up to six tables or figures. All research papers should follow relevant reporting guidelines such as CONSORT for trials, COREQ for qualitative research etc. Please see http://www.equator-network.org/resource-centre/library-of-health-research-reporting/ for up to date information on reporting guidelines, and fuller instructions below on constructing different aspects of the paper. For papers reporting qualitative methods participants' quotations may be excluded from the word count. We still prefer, however, that these quotations are succinct and carefully chosen - it is rare that more than one quote is required to illustrate the point being made.
    3. Short reports - 1,000-1,400 words. These should report research, but are usually small scale survey/pilot/feasibility studies etc, which would not warrant a full original research paper
    4. Case reports - 1,000-1,400 words with one table or figure. We have specific and explicit requirements for case report abstracts and the construction of the report (see below) which must be followed. Case reports must be used to generate future research questions.
    5. Audit and Service Evaluation. 1, 000 - 1,400 words. We do accept audit and service evaluation reports, but these should be of exceptional quality and interest. They should be clearly identified as audit or service evaluation in the title. These should be robustly reported - we expect audits to discuss the audit cycle and feedback, and service evaluations to report sufficient contextual information on the service being evaluated. They should be used to raise future research questions. Full details of all relevant permissions and consents should be reported.
    6. Research letters. We occasionally publish short research letters (750 words, no abstract required, no more than 3 references). These are usually offered as a publication type to authors submitting original papers or short reports which we feel should be disseminated, but in a more succinct form.
    7. Letters to the editors. We welcome correspondence relating to issues of general interest to our readership, or in response to a publication. Such letters should be succinct, and generally no more than 500 - 750 words.

    NB: word count excludes references, tables and figures references.

    We expect that full details of any ethics/research governance/data protection approvals are given, with reference numbers. If research ethics committee/IRB approvals were not required for your work can you please reference the law or regulation granting exemption, and/or submit a letter from the relevant authorities granting this study exemption. This must be clear within the body of the paper. We expect in all circumstances that the highest possible standards of research ethics and governance are followed and demonstrated throughout the paper.

    Back to top

     

    1.2 Titles and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article, and please ensure that your article, if published, reaches the widest possible readership. This means paying attention to retrieval items such as the title, abstract and keywords. A significant proportion of readers come to the Palliative Medicine site by running simple keyword searches. It’s important therefore that an article’s title, keywords and abstract are written to be optimally “discoverable” by search engines. Please read and follow these guidelines http://www.uk.sagepub.com/authors/journal/readership.sp. Key tips include repeating key phrases within the abstract and between the abstract and keywords - think about what key phrases you would give a search engine if you were searching for the article. Repetition of a particular key phrase may strengthen the ranking of the article. Getting the title right - ensure the main key phrase for the topic is in the article title. Make sure the title is clear, descriptive, unambiguous, accurate and reads well. Titles should reflect the methods used within the paper. We do not recommend the use of country names in titles as there is evidence this can restrict readership, countries can be mentioned in the abstract. There is evidence that putting the findings of the paper in the title can attract readership. Keywords should be MeSH headings and should be checked against this list http://www.nlm.nih.gov/mesh/.

    Back to top

     

    Structured abstracts

    Reviews, original articles, short reports, case reports, audits and service evaluations should be accompanied by a structured abstract. Full details are given below of the format we expect for these:

    Research Paper/Short Report/Audit/Service Evaluation:

    Abstracts should have clear headings, which should generally follow the structure below when reporting research, but may vary depending on the requirements of the reporting guidelines followed. There is some flexibility for audit/service evaluation as it is important that these are not presented as research.

    Background: Identify the issue to be addressed, current knowledge on the topic and some indication of its relevance and importance to clinical practice, theory or research methodology.
    Aim: A clear statement of the main research aim(s), research question (s) or hypotheses to be tested.
    Design: A statement about the research strategy adopted. For intervention studies, a clear statement of the intervention is required. For clinical trials, the trial number should be given.
    Setting/participants: Indicate the type of setting(s) the research was conducted in (i.e. primary/secondary care), the number of centres, and who participated including brief indication of inclusion/exclusion criteria, numbers of participants and any relevant characteristics.
    Results: Report the main outcomes(s) findings of the study. If appropriate, report levels of statistical significance and confidence intervals.
    Conclusions: Identify how the aims have been met, and the relevance of the findings for clinical practice, theory or research methodology. Suggestions for further research.

    Review Paper

    These should generally follow the structure below, with reference to relevant review reporting guidelines such as PRISMA.

    Background: Identify the issue to be addressed, current knowledge on the topic and some indication of its relevance and importance to clinical practice, theory or research methodology.
    Aim: A clear statement of the review aim(s).
    Design: A statement about the review strategy/methods adopted
    Data sources: State the data sources used (including years searched). Include a statement about eligibility criteria for selecting studies and study quality appraisal
    Results: Report the main outcomes(s) /findings of the review.
    Conclusions: Identify how the aims have been met, and the relevance of the findings for clinical practice, theory or research methodology.

    Case Report

    This format differs from our structured abstracts for research or reviews, so please ensure you follow the correct format or your paper will be returned without review. Case report abstracts should be 200 words in length.

    Background: Identify the issue the case report addresses, why this case is important, current knowledge on the topic, and some indication of the case relevance to practice and research.
    Case Presentation: Presenting features of the case(s) and working/differential diagnoses. Brief summary of case(s) history, examinations and investigations etc.
    Case Management: Details of any treatment given and a description of the course of the clinical issue(s) being reported.
    Case Outcome: Description of case(s) outcome. Details of any outcome measures used.
    Conclusions: Identify how the aims have been met, and the relevance of the findings for clinical practice, theory or research methodology. Suggestions for further research.

    Back to top

     

    1.3 Key statements

    Palliative Medicine has a system where all papers are required to clearly state what is already known about the topic, what their paper adds, and implications for practice, theory, or policy. You are required to give these at the start of the manuscript. Please use these three specific headings (see below), with 1-3 separate bullet points for each heading. Please use clear, succinct, separate bullet points rather than complex or multiple sentences. Each bullet point should be one sentence only.

    What is already known about the topic?

    • Short statement(s) here about state of knowledge in this area.
    • You may highlight both what is known and what is not known.
    • Be specific rather than broad or sweeping statements. Avoid statements such as 'Little is known about ... x or y' in favour of statements specifying exactly what is known.

     

    What this paper adds?

    • Short specific statement(s) here about what this paper adds.
    • These should be styled in terms of outcomes where possible (This study demonstrates that x intervention has a (specific) impact on y outcome) rather than study aims or process. (This study considers whether x intervention has an impact of y outcome).
    • Be as specific as possible please here. Avoid broad statements such as 'New Knowledge is added about ... ' but rather be specific about exactly what this knowledge is. So for example rather than 'We add to the knowledge base on x' we would prefer the specific such as 'x variable was found to increase the experience of y outcome (by z amount)'.
    • Ensure that these statements clearly relate to the findings of the study.

    Implications for practice, theory or policy?

    • Short specific statement(s) here on the implications of this paper for practice, theory or policy. These should clearly draw from the findings of the study, without over stating their importance.
    • Where possible please make these internationally relevant.

    Back to top

     

    1.4 Study discussion

    Although Palliative Medicine does not require structured discussions, we would like you to bear in mind the typical content for a structured discussion when writing your paper. This would typically be a statement of the principal findings of the study, a discussion of the strengths and weaknesses of the study/review with reference to other studies or reviews in the area, a discussion of what is already known about this topic and what this research/review adds, and a discussion of the implications of the research/review for clinical practice, theory or methods in this area. You may wish to raise further research or review questions.

    Back to top

     

    1.5 Case report instructions for Palliative Medicine

    The purpose of our case reports: We are interested in publishing unusual clinical presentations or novel approaches to care. As a research focused journal, we publish case reports to highlight issues of clinical interest which help readers to pose research questions for future further study, and so we want these research focused learning points to be explicit within the report.

    Case report length: Case reports should be succinct and focused. They should be between 1000 and 1400 words in length. The aim is description of the case, without undue speculation.

    Case report instructions: Case report authors should also read our general instructions to authors regarding title, keywords, article retrievability, authorship and other general formatting issues. Case reports should include the words ‘case report’ or ‘case series’ as appropriate in the title and keywords. Please do not use ‘case study’ as this leads to confusion with the research strategy of the same name.

    Back to top

     

    1.6 Case report format

    The format for the written case report should, where possible, follow the same structured format as for the abstract, but in greater detail.

    Background: Identify the issue the case report addresses, why this case is important, current knowledge on the topic, and some indication of the case relevance to practice and research. The case should be placed in context, remembering that Palliative Medicine is an international journal and readers are unlikely to be familiar with the particular context in which this case(s) occurred. You should briefly make reference to any similar published cases, and related research findings.

    Case presentation: Presenting features of the case(s) and working/differential diagnoses. Brief summary of case(s) history, examinations and investigations etc. Cases presented in Palliative Medicine should be anonymised. Sufficient detail should be given so that the case is informative to the reader, but the patient should not be able to be identified from the case information. Details should be given in this section or in a final ‘consent’ section of the permissions the patient(s) gave for their case(s) to be written for publication. Where possible patients should sign an informed consent form which is submitted as a supplementary file to the case report, and this should be noted in the report. We do expect written informed consent for most of the case reports we publish, however we acknowledge that this can be challenging in the field of palliative care with potentially rapidly deteriorating patients. If the patient has died, as a next step we would expect the authors to request permission from a relative, and make this clear on the consent form and in the report. If no written consent is possible from either patient or relative we will carefully consider the utility of the case against the likelihood of identification or potential distress. To reduce the possibility of identification then it is likely that in this position more information will have to be removed from the case, and this will have to be made clear in the report.

    Case management: Details of any treatment given and a description of the course of the clinical issue(s) being reported. Drug names should be generic not proprietary. Details of management should be specific and described to be understandable by those who may follow different protocols in different contexts. A rationale should be given for any changes in management. An indication of timescale should be included.

    Case outcome: Description of case(s) outcome. Details of any outcome measures used.

    Conclusions: Indication of novelty of this case(s) with reference to other published cases and any existing research. Description of lessons learnt from the case(s) and implications for future research. It is particularly important that these learning points from the case are clearly spelt out. In particular, as a research journal, we expect a clear statement of the research questions or areas that could be investigated that follow from this case(s).

    Case reports should usually have no more than 8 references and include no more than 1 table or figures.

    Back to top

     

    2. Editorial policies

    Back to top

     

    2.1 Peer review policy

    Palliative Medicine operates a conventional single blind reviewing policy in which the reviewer's name is always concealed from the submitting authors. All submitted manuscripts undergo a two stage review process. The initial review is undertaken by a number of editors and a decision is made either to send the paper for external review or to reject it without review. We undertake to make the decision whether or not to send for external review within three weeks of submission. In this initial review the editors ensure that only those papers that meet the scientific and editorial standards of the journal and fit within the aims and scope of the journal will be sent for external review. Papers accepted for publication following external review usually require some modification before final acceptance. Generally, due to the high volume of submissions, we are able to accept only about 30% of papers submitted to us.

    As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below:

    • The reviewer should have no prior knowledge of your submission
    • The reviewer should not have recently collaborated with any of the authors
    • Reviewer nominees from the same institution as any of the authors are not permitted

    Please note that the Editors are not obliged to invite any recommended/opposed reviewers to assess your manuscript.

    Back to top

     

    2.2 Authorship

    Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

    1. Made a substantial contribution to the concept and design, acquisition of data or analysis and interpretation of data,
    2. Drafted the article or revised it critically for important intellectual content,
    3. Approved the version to be published.

    Authors should meet the conditions of all of the points above. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.
    When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    Back to top

     

    2.3 Multiple publications

    We want our readers to be aware of other published or in-press accounts of any studies published in Palliative Medicine. For this reason we ask that all published and in-press accounts of the study from which data in your paper are taken must be explicitly referred to in your paper. Please make it clear in your manuscript that you are referring to data/publications from the same study. If you have other publications from the same study in preparation or under review please refer to this in your letter to the editor. If you are successful in your submission to Palliative Medicine we ask that where possible this publication should be referred to in other manuscripts using data from the same study.

    Back to top

     

    2.4 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    Back to top

     

    2.5 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance - including the individual’s name, company and level of input - and identify the entity that paid for this assistance”).

    It is not necessary to disclose use of language polishing services.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    Back to top

     

    2.6 Funding

    Palliative Medicine requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

    Back to top

     

    2.7 Declaration of conflict of interest

    It is the policy of Palliative Medicine to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’.

    For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    Back to top

     

    2.8 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    Back to top

     

    2.9 Clinical trials

    Palliative Medicine endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable. The trial registry name and URL, and registration number must be included at the end of the abstract.

    Back to top

     

    2.10 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart as a cited figure, and a completed CONSORT checklist as a supplementary file.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    Back to top

     

    2.11 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Palliative Medicine requests all authors to provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editor may consider limited embargoes on proprietary data. The editor can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations. For further information, please contact Debbie Ashby [Debbie.Ashby@bristol.ac.uk].

    Back to top

     

    3. Publishing policies

    Back to top

     

    3.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway

    Back to top

     

    3.2 Plagiarism

    Palliative Medicine and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal or all SAGE journals, or appropriate legal action.

    Back to top

     

    3.3 Contributor’s publishing agreement

    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    Back to top

     

    3.4 Open access and author archiving

    Palliative Medicine offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

    Back to top

     

    3.5 Permissions

    Authors are responsible for obtaining permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please visit our Frequently Asked Questions on the SAGE Journal Author Gateway.

    Back to top

     

    4. Preparing your manuscript

    Back to top

     

    4.1 Word processing formats

    Preferred formats for the text and tables of your manuscript are Word DOC, RTF, and XLS. LaTeX files are also accepted. The text should be double-spaced throughout and with a minimum of 3cm for left and right hand margins and 5cm at head and foot. Text should be standard 10 or 12 point. Word and LaTex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    Back to top

     

    4.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.

    Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.

    Back to top

     

    4.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc.) alongside the full-text of the article. These will be subjected to peer-review alongside the article. For more information please refer to our guidelines on submitting supplementary files, which can be found within our Manuscript Submission Guidelines page.

    Back to top

     

    4.4 Journal layout

    Palliative Medicine conforms to the SAGE house style. Click here to review guidelines on SAGE UK House Style.

    Back to top

     

    4.5 Reference style

    Palliative Medicine adheres to the SAGE Vancouver reference style. Click here to review the guidelines on SAGE Vancouver to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver output file here.

    Back to top

     

    4.6 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

     

    5. Submitting your manuscript

     

    5.1 How to submit your manuscript

    Palliative Medicineis hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/palliative-medicine to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created. For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    Back to top

     

    5.2 Title, keywords and abstracts

    Please supply a title, short title, an abstract and keywords to accompany your article. The title, keywords and abstract are key to ensuring readers find your article online through online search engines such as Google. Please refer to the information and guidance on how best to title your article, write your abstract and select your keywords by visiting the SAGE Journal Author Gateway for guidelines on How to Help Readers Find Your Article Online.

    Back to top

     

    5.3 Corresponding author contact details

    Provide full contact details for the corresponding author including email, mailing address and telephone numbers. Academic affiliations are required for all co-authors. These details should be presented separately to the main text of the article to facilitate anonymous peer review.

    Back to top

     

    6. On acceptance and publication

     

    6.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.

    Back to top

     

    6.2 Access to your published article

    SAGE provides authors with online access to their final article.

    Back to top

     

    6.3 Online First publication

    Online First allows final revision articles (completed articles in queue for assignment to an upcoming issue) to be published online prior to their inclusion in a final journal issue which significantly reduces the lead time between submission and publication. For more information please visit our Online First Fact Sheet

    Back to top

     

    7. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Palliative Medicine editorial office as follows:

    Debbie Ashby
    Editorial Manager
    debbie.ashby@bristol.ac.uk

    Back to top

    Please select a format:

    Individual, Single Print Issue

    £28.00
    $52.00

    Institutional, Single Print Issue

    £154.00
    $285.00

    Member Subscription, Combined (Print & E-access)

    £166.00
    $307.00

    Individual Subscription, Combined (Print & E-access)

    £215.00
    $398.00

    Professional Institution Subscription, Combined (Print & E-access)

    £715.00
    $1,322.00

    Institutional Subscription, E-access

    £1,286.00
    $2,380.00

    Institutional Backfile Purchase, E-access (Content through 1998)

    £1,339.00
    $2,476.00

    Institutional Subscription, Print Only

    £1,400.00
    $2,591.00

    Institutional Subscription & Backfile Lease, E-access Plus Backfile (All Online Content)

    £1,429.00
    $2,644.00

    Institutional Subscription, Combined (Print & E-access)

    £1,429.00
    $2,644.00

    Institutional Subscription & Backfile Lease, Combined Plus Backfile (Current Volume Print & All Online Content)

    £1,572.00
    $2,908.00